DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Markets for Orphan Drugs" report to their offering.
The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019, demonstrating a compound annual growth rate (CAGR) of 9.2% during the forecast period (2014 to 2019).
The biological orphan drug market should reach $126.1 billion in 2019, while the non-biological orphan drug market is anticipated to grow to $64.8 billion during the same forecast period.
This report provides:
- An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence, advantages inherent in orphan drug designation, and future growth trends
- Detailed discussion of successful orphan products
- Detailed analysis of blockbuster orphan drugs
- The rising influence of pharmacogenomics in the orphan drug market
- A discussion of specific rare diseases for which orphan drugs exist
- Analysis of the most promising therapeutic areas in the industry and leading orphan drugs in these areas
- An outline of legislation and regulation, including public and private agencies involved in support and development
- Technology trends analysis within the orphan drug market
- Comprehensive company profiles of major players in the industry
Use this report to:
- Receive a detailed analysis of the industry's structure with revenues categorized by region as well as sales estimates for the period from 2014 through 2019.
- Learn about the current and future strategies within the orphan drug market, which includes both biological and non-biological orphan drugs.
- Analyze the therapeutic applications of orphan drugs in rare and orphan diseases as well as regulatory framework, patents, and recent innovations.
-
Receive information about the significant patents and their allotments
in each category.
Key Topics Covered:
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Overview
Chapter 4: Regulatory Aspects
Chapter 5: New Developments
Chapter 6: Market Analysis
Chapter 7: Industry Structure
Chapter 8: Market By Application
Chapter 9: Patent Analysis
Chapter 10: Current Trends
Companies Mentioned:
- Acorda Therapeutics
- Actelion Pharmaceuticals Ltd.
- Aegerion Pharmaceuticals
- Alexion Pharmaceuticals
- Amgen
- Baxter International
- Bayer Healthcare Pharmaceuticals
- Biogen Idec
- Biomarin Pharmaceutical Inc.
- Bristol-Myers Squibb
- Cangene Corp.
- Celgene
- Genzyme
- Gilead Sciences Inc.
- Glaxosmithkline
- Johnson & Johnson
- Lundbeck Llc
- Merck
- Novartis
- Novo Nordisk Inc.
- Onyx Therapeutics
- Pfizer Inc.
- Roche
- Seattle Genetics
- Shire Plc
- Takeda Pharmaceutical U.S.A. Inc.
- Vectura Group Plc
-
Vertex Pharmaceuticals
For more information visit http://www.researchandmarkets.com/research/ft6fsm/global_markets
